Investor Relations

Latest Company Reports

Annual Report 2021
Sustainability Report 2021
Governance Report 2021

Interim Report

Q1 2022 Cambio Report

Q1 2022 Cambio Report

Financial calender

Feb 18, 2022. Interim report Q4 2021, Full year.
Apr 29, 2022. Annual Report 2021.
May 31, 2022. Interim report Q1 2022, January – March,
Aug 19, 2022. Interim report Q2 2022, January – June,
Nov 30, 2022. Interim report Q3 2022, January – September.
Feb 28, 2023. Interim report Q4 2022, January – December.

Other documents

Terms and Conditions (Executed)
Organisation, Sanolium AB
Prospectus
Prospectus

Regulatory reports

2022-08-19

Sanolium AB interim report, April – June 2022

2022-07-21
Cambio and FRISQ enters into a formal exclusive process to divest FRISQ to Cambio

2022-05-31
Sanolium AB interim report, January – March 2022

2022-05-20
Sanolium AB (publ) publishes bond prospectus and applies for listing of subsequent bonds on Nasdaq Stockholm

2022-05-06
Johannes Fabó new Chief Financial Officer at Cambio

2022-05-03
Successful transaction Sanolium AB (publ) has successfully issued subsequent senior secured bonds of SEK 300m

2022-04-28
Sanolium AB publishes annual report and sustainability report for 2021

2022-04-28
Tap issue, Sanolium AB (publ) up to SEK 300m Senior Secured Bond tap issue

2021-04-19
Press release, Sanolium announces leadership transition

2020-08-21
Press release, Sanolium AB, Q2 2020 Interrim report

2020-08-17
Sanolium AB (publ) publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm

2019-09-20
Cambio issues inaugural bond with exceptional outcome

2019-09-10
Sanolium AB contemplates issuance of SEK bonds

2019-07-18
Cambio förvärvar Daintel

2019-02-02
Ledande investmentbolag blir ny huvudägare i Cambio Healthcare Systems